Fink; Brian E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fink; Brian E..The latest application filed is for "agonists of ror gammat".
Company Profile
13.40.47
- Fink; Brian E. - Yardley PA
- Fink; Brian E. - West Windsor NJ
- Fink; Brian E. - Princeton Junction NJ
- Fink, Brian E. - Priceton Junction NJ
Patent Activity
| Patent | Date |
|---|---|
| AGONISTS OF ROR GAMMAt App 20220306630 - Harikrishnan; Lalgudi S. ; et al. | 2022-09-29 |
| Cyclic dinucleotides as anticancer agents Grant 11,427,610 - Fink , et al. August 30, 2 | 2022-08-30 |
| Cyclic dinucleotides as anticancer agents Grant 11,339,185 - Fink , et al. May 24, 2 | 2022-05-24 |
| Cyclic Dinucleotides As Anticancer Agents App 20220117995 - FINK; Brian E. ; et al. | 2022-04-21 |
| Cyclic Dinucleotides As Anticancer Agents App 20210253624 - FINK; Brian E. ; et al. | 2021-08-19 |
| Cyclic dinucleotides as anticancer agents Grant 10,953,032 - Dodd , et al. March 23, 2 | 2021-03-23 |
| Cyclic dinucleotides as anticancer agents Grant 10,947,263 - Qin , et al. March 16, 2 | 2021-03-16 |
| Cyclic Dinucleotides As Anticancer Agents App 20210002323 - FINK; Brian E. ; et al. | 2021-01-07 |
| Cyclic dinucleotides as anticancer agents Grant 10,744,150 - Fink , et al. A | 2020-08-18 |
| Cyclic Dinucleotides As Anticancer Agents App 20200253997 - Kind Code | 2020-08-13 |
| Cyclic Dinucleotides As Anticancer Agents App 20200223883 - Qin; Lan-Ying ; et al. | 2020-07-16 |
| Cyclic Dinucleotides As Anticancer Agents App 20200079815 - FINK; Brian E. ; et al. | 2020-03-12 |
| Cyclic dinucleotides as anticancer agents Grant 10,519,187 - Fink , et al. Dec | 2019-12-31 |
| TGF beta receptor antagonists Grant 10,399,987 - Harikrishnan , et al. Sep | 2019-09-03 |
| Cyclic Dinucleotides As Anticancer Agents App 20190248828 - Fink; Brian E. ; et al. | 2019-08-15 |
| TGF.beta. receptor antagonist Grant 10,336,761 - Harikrishnan , et al. | 2019-07-02 |
| TGF beta receptor antagonists Grant 10,292,985 - Borzilleri , et al. | 2019-05-21 |
| Cyclic Dinucleotides As Anticancer Agents App 20190030057 - FINK; Brian E. ; et al. | 2019-01-31 |
| Tgf Beta Receptor Antagonists App 20180250303 - Borzilleri; Robert M. ; et al. | 2018-09-06 |
| Tgf Beta Receptor Antagonists App 20180243312 - BORZILLERI; Robert M. ; et al. | 2018-08-30 |
| Tgf Beta Receptor Antagonists App 20180215761 - HARIKRISHNAN; Lalgudi S. ; et al. | 2018-08-02 |
| Tgf Beta Receptor Antagonists App 20180215762 - HARIKRISHNAN; Lalgudi S. ; et al. | 2018-08-02 |
| TGF.beta.R antagonists Grant 9,708,316 - Fink , et al. July 18, 2 | 2017-07-18 |
| Imidazotriazinecarbonitriles useful as kinase inhibitors Grant 9,556,178 - Purandare , et al. January 31, 2 | 2017-01-31 |
| Tgf Beta R Antagonists App 20160176871 - Fink; Brian E. ; et al. | 2016-06-23 |
| Imidazopyridazinecarbonitriles useful as kinase inhibitors Grant 9,371,328 - Fink , et al. June 21, 2 | 2016-06-21 |
| Imidazotriazinecarbonitriles Useful As Kinase Inhibitors App 20160108050 - Purandare; Ashok Vinayak ; et al. | 2016-04-21 |
| Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof Grant 9,273,014 - Gavai , et al. March 1, 2 | 2016-03-01 |
| Prodrugs of 1,4-benzodiazepinone compounds Grant 9,273,075 - Gavai , et al. March 1, 2 | 2016-03-01 |
| Imidazotriazinecarbonitriles useful as kinase inhibitors Grant 9,273,057 - Purandare , et al. March 1, 2 | 2016-03-01 |
| Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,242,941 - Gavai , et al. January 26, 2 | 2016-01-26 |
| Fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,133,139 - Gavai , et al. September 15, 2 | 2015-09-15 |
| Alkyl, Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150239851 - Gavai; Ashvinikumar V. ; et al. | 2015-08-27 |
| Prodrugs Of 1,4-benzodiazepinone Compounds App 20150232491 - Gavai; Ashvinikumar V. ; et al. | 2015-08-20 |
| Fluoroalkyl And Fluorocycloalkyl 1,4-benzodiazepinone Compounds App 20150231152 - Zhao; Yufen ; et al. | 2015-08-20 |
| Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150218111 - Gavai; Ashvinikumar V. ; et al. | 2015-08-06 |
| Imidazotriazinecarbonitriles Useful As Kinase Inhibitors App 20150210697 - Purandare; Ashok Vinayak ; et al. | 2015-07-30 |
| Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof App 20150166489 - Gavai; Ashvinikumar V. ; et al. | 2015-06-18 |
| Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof Grant 8,999,918 - Gavai , et al. April 7, 2 | 2015-04-07 |
| Imidazotriazinecarbonitriles Useful As Kinase Inhibitors App 20150065465 - Purandare; Ashok Vinayak ; et al. | 2015-03-05 |
| Imidazotriazinecarbonitriles useful as kinase inhibitors Grant 8,940,736 - Purandare , et al. January 27, 2 | 2015-01-27 |
| Substituted pyrrolotriazines as protein kinase inhibitors Grant 8,791,257 - Markwalder , et al. July 29, 2 | 2014-07-29 |
| Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors App 20140179674 - Fink; Brian E. ; et al. | 2014-06-26 |
| Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds And Prodrugs Thereof App 20140087992 - Gavai; Ashvinikumar V. ; et al. | 2014-03-27 |
| Imidazotriazinecarbonitriles Useful As Kinase Inhibitors App 20140018319 - Purandare; Ashok Vinayak ; et al. | 2014-01-16 |
| Substituted imidazopyridazines useful as kinase inhibitors Grant 8,389,527 - Fink , et al. March 5, 2 | 2013-03-05 |
| Substituted Pyrrolotriazines As Protein Kinase Inhibitors App 20130023514 - Markwalder; Jay A. ; et al. | 2013-01-24 |
| Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors App 20120283241 - Fink; Brian E. ; et al. | 2012-11-08 |
| Pyrrolotriazine kinase inhibitors Grant 8,268,998 - Fink , et al. September 18, 2 | 2012-09-18 |
| Imidazopyridazinecarbonitriles useful as kinase inhibitors Grant 8,252,795 - Fink , et al. August 28, 2 | 2012-08-28 |
| Intermediates useful in preparing certain pyrrolotriazine compounds and a process for making the intermediates Grant 8,148,523 - Fink April 3, 2 | 2012-04-03 |
| Pyrrolotriazine Kinase Inhibitors App 20110245252 - Fink; Brian E. ; et al. | 2011-10-06 |
| Pyrrolotriazine kinase inhibitors Grant 7,982,033 - Fink , et al. July 19, 2 | 2011-07-19 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20110039838 - Fink; Brian E. ; et al. | 2011-02-17 |
| Substituted Imidazopyridazines Useful As Kinase Inhibitors App 20100323994 - Fink; Brian E. ; et al. | 2010-12-23 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,846,931 - Fink , et al. December 7, 2 | 2010-12-07 |
| Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function Grant 7,776,859 - Balog , et al. August 17, 2 | 2010-08-17 |
| Imidazopyridazinecarbonitriles Useful As Kinase Inhibitors App 20100113458 - Fink; Brian E. ; et al. | 2010-05-06 |
| Pyrrolotriazine Kinase Inhibitors App 20100081662 - Fink; Brian E. ; et al. | 2010-04-01 |
| Intermediates Useful In Preparing Certain Pyrrolotriazine Compounds And A Process For Making The Intermediates App 20100056781 - Fink; Brian E. | 2010-03-04 |
| Pyrrolotriazine kinase inhibitors Grant 7,605,160 - Fink , et al. October 20, 2 | 2009-10-20 |
| Anthranilic acid derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 Grant 7,569,725 - Kick , et al. August 4, 2 | 2009-08-04 |
| Pyrrolotriazine kinase inhibitors Grant 7,531,539 - Fink , et al. May 12, 2 | 2009-05-12 |
| Pyrrolotriazine kinase inhibitors Grant 7,514,435 - Chen , et al. April 7, 2 | 2009-04-07 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20090048244 - Fink; Brian E. ; et al. | 2009-02-19 |
| Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 Grant 7,417,040 - Fink , et al. August 26, 2 | 2008-08-26 |
| Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 Grant 7,378,426 - Gavai , et al. May 27, 2 | 2008-05-27 |
| Pyrrolotriazine Kinase Inhibitors App 20080058337 - Fink; Brian E. ; et al. | 2008-03-06 |
| Pyrrolotriazine Kinase Inhibitors App 20080045496 - Fink; Brian E. ; et al. | 2008-02-21 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,297,695 - Fink , et al. November 20, 2 | 2007-11-20 |
| Pyrrolotriazine Kinase Inhibitors App 20070149534 - Chen; Ping ; et al. | 2007-06-28 |
| Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function App 20070088039 - Balog; James Aaron ; et al. | 2007-04-19 |
| C-6 modified indazolylpyrrolotriazines Grant 7,148,220 - Vite , et al. December 12, 2 | 2006-12-12 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,141,571 - Fink , et al. November 28, 2 | 2006-11-28 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20060264438 - Fink; Brian E. ; et al. | 2006-11-23 |
| Anthranilic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 App 20060135619 - Kick; Ellen K. ; et al. | 2006-06-22 |
| Di-substituted pyrrolotriazine compounds Grant 7,064,203 - Gavai , et al. June 20, 2 | 2006-06-20 |
| Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 App 20050250753 - Fink, Brian E. ; et al. | 2005-11-10 |
| C-6 modified indazolylpyrrolotriazines App 20050222153 - Vite, Gregory D. ; et al. | 2005-10-06 |
| Di-substituted pyrrolotrizine compounds App 20050197339 - Gavai, Ashvinikumar V. ; et al. | 2005-09-08 |
| Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 App 20050192310 - Gavai, Ashvinikumar V. ; et al. | 2005-09-01 |
| Pyrrolotriazine compounds as kinase inhibitors App 20050182058 - Fink, Brian E. ; et al. | 2005-08-18 |
| C-6 modified indazolylpyrrolotriazines Grant 6,916,815 - Vite , et al. July 12, 2 | 2005-07-12 |
| C-6 modified indazolylpyrrolotriazines App 20040142931 - Vite, Gregory D. ; et al. | 2004-07-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 